Is Sea Moss Good for Fatty Liver?

Sea moss is increasingly popular as a health supplement, but is sea moss good for fatty liver disease? Fatty liver disease affects a significant proportion of UK adults and is primarily managed through lifestyle changes guided by NHS and NICE recommendations. With social media promoting sea moss as a natural remedy for a wide range of conditions, it is important to examine what the evidence actually shows. This article explores the nutritional profile of sea moss, what science says about its effects on liver health, and what interventions are genuinely supported by clinical evidence for managing fatty liver disease.

What is fatty liver disease and how is it managed on the NHS?

Fatty liver disease involves excess fat in liver cells and is managed on the NHS primarily through lifestyle modification, as no medicine is currently licensed specifically for MASLD in the UK. NICE guidance (NG49) recommends dietary change, weight loss and regular monitoring, with GP referral to a specialist if disease is more advanced.

Fatty liver disease is a condition in which excess fat accumulates within liver cells, and it is broadly divided into alcohol-related liver disease (ARLD) and metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD). MASLD is closely linked to obesity, type 2 diabetes, high cholesterol and insulin resistance, and it affects a significant proportion of the UK adult population.^[5][1] In many cases the condition causes no symptoms in its early stages, but without intervention it can progress to inflammation, fibrosis, cirrhosis and, in some cases, liver failure.

On the NHS, diagnosis typically involves blood tests to assess liver function, an ultrasound scan, and in some cases a FibroScan or liver biopsy to assess the degree of scarring. NICE guidance (NG49) recommends that management of MASLD centres on lifestyle modification.^[1] No medicine is currently licensed specifically for MASLD in the UK, though you should confirm the current position with your GP or specialist, as the licensing landscape can change.^[3][4] NICE NG49 also recommends that non-invasive fibrosis scores, such as the FIB-4 score or the NAFLD Fibrosis Score, are used in primary care to identify people who need further assessment, and the Enhanced Liver Fibrosis (ELF) test is used in secondary care; your clinician can explain which applies to you and what the results mean.

Your GP is the appropriate first point of contact if you are concerned about your liver health, and referral to a hepatology or gastroenterology specialist may follow if the disease is more advanced. Regular monitoring is important because fatty liver disease can be silent for years. People with type 2 diabetes, obesity or metabolic syndrome are at higher risk and may be offered targeted case finding rather than routine screening, as NICE does not recommend population-wide screening for MASLD.^[1][2]

Seek urgent medical attention if you develop any of the following, as they may indicate serious liver disease or another urgent condition:

• Yellowing of the skin or whites of the eyes (jaundice)

• Vomiting blood or passing black, tarry stools

• New or rapidly worsening confusion or drowsiness

• Marked swelling of the abdomen

• Severe pain in the upper right abdomen

• High fever with shaking chills

If you experience any of these symptoms, contact NHS 111, attend your nearest A&E, or call 999 if symptoms are severe or rapidly worsening. For persistent but non-urgent symptoms such as fatigue or mild right-sided abdominal discomfort, contact your GP promptly rather than waiting for a routine appointment.

What does sea moss contain that might affect liver health?

Sea moss contains iodine, dietary fibre, polysaccharides, B vitamins and minerals, but iodine levels vary considerably and excessive intake can disrupt thyroid function. Environmental contaminants such as heavy metals may also be present depending on where the seaweed is harvested.

Sea moss is a term applied to several species of red algae, most commonly Chondrus crispus, though products sold under this name may also contain Gracilaria or other species. This distinction matters because iodine content, nutrient profile and potential contaminant levels can differ considerably between species, growing locations and preparation methods. Sea moss contains a range of nutrients sometimes cited in discussions about liver health, including iodine, potassium, magnesium, B vitamins, and dietary fibre in the form of carrageenan and other polysaccharides. Proponents suggest these components could support metabolic function, reduce inflammation or assist in detoxification, though these claims require careful scrutiny in the context of clinical evidence.

The iodine content of sea moss is particularly notable and warrants caution. Iodine levels can vary considerably depending on species, origin and processing, and excessive iodine intake can disrupt thyroid function, which in turn may affect metabolic rate and liver health indirectly. The British Dietetic Association advises that iodine supplements, including those derived from seaweed, should be used with care, particularly in people with existing thyroid conditions.^[6][7] The Food Standards Agency (FSA) has also highlighted that seaweed products can contain high and variable amounts of iodine, and advises that people who are pregnant or breastfeeding should avoid seaweed supplements because of the risk of excessive iodine exposure to the developing baby or infant.^[9][10]

Seaweed products, including sea moss, may also contain environmental contaminants such as heavy metals, depending on where they are harvested. The FSA advises sourcing seaweed products from reputable suppliers and checking that products have been tested for contaminants.

Sea moss also contains sulphated polysaccharides, which have attracted interest in laboratory research for potential anti-inflammatory and antioxidant properties. Some animal studies have explored whether these compounds might reduce hepatic fat accumulation or oxidative stress in liver tissue. However, it is important to distinguish between findings in cell cultures or animal models and evidence from human clinical trials, as the two do not always translate. The nutrient profile of sea moss may fit within a balanced diet, but no single component has been shown in robust human studies to directly reverse or treat fatty liver disease, and carrageenan's potential effects on liver endpoints in humans remain unproven.

Is there any clinical evidence that sea moss helps a fatty liver?

There is no robust clinical evidence from human trials that sea moss improves or reverses fatty liver disease; it is not included in NICE or NHS clinical pathways for MASLD. Animal and laboratory studies exist but have not been replicated in well-designed human randomised controlled trials.

There is currently no robust clinical evidence from human trials demonstrating that sea moss improves or reverses fatty liver disease. While a small number of animal studies and in vitro experiments have investigated the effects of red algae extracts on liver fat and inflammation, these findings have not been replicated in well-designed, peer-reviewed randomised controlled trials involving human participants. Sea moss is not recommended in NICE guidance (NG49) or NHS clinical pathways for the management of MASLD.

Some observational research suggests that diets rich in plant-based foods, fibre and antioxidants are associated with better liver health outcomes, and sea moss does contribute these elements when consumed as part of a varied diet. However, attributing any liver benefit specifically to sea moss, rather than to overall dietary quality, is not supported by current evidence.

It is also worth noting that sea moss supplements are regulated as food supplements in the UK rather than as licensed medicines. This means they are not subject to the same pre-market safety, efficacy and quality assessments as medicines authorised by the MHRA. Product quality, purity and iodine content can therefore vary significantly between brands. The FSA provides guidance on food supplement safety, and the MHRA publishes information on borderline products to help consumers understand how different products are regulated.

If you are considering sea moss as a supplement, discuss this with your GP or a registered dietitian before starting, particularly if you have an existing liver condition, thyroid disorder or are taking prescribed medication. Supplements can interact with medicines and may not be appropriate for everyone. Any suspected adverse effects from a supplement should be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

What lifestyle changes actually improve fatty liver disease?

Sustained weight loss of 7 to 10 per cent of body weight through dietary change and physical activity is the most evidence-based intervention for MASLD, supported by NICE NG49 and EASL-EASD-EASO 2024 guidelines. A Mediterranean-style diet and at least 150 minutes of moderate-intensity exercise per week are specifically recommended.

Sustained weight loss through a combination of dietary change and increased physical activity is the most evidence-based intervention for improving fatty liver disease, and NICE guidance (NG49) supports this approach as the cornerstone of management. Evidence cited in NICE NG49 and the EASL-EASD-EASO 2024 clinical practice guidelines on MASLD indicates that losing 7 to 10 per cent of body weight can lead to meaningful reductions in liver fat, inflammation and fibrosis in people with MASLD.^[13][1] Even modest weight loss of 3 to 5 per cent can reduce hepatic steatosis, making gradual, sustainable progress more valuable than rapid or extreme dieting.^[13][1]

Dietary recommendations for fatty liver disease align closely with general healthy eating guidance:

• Reduce intake of ultra-processed foods, refined carbohydrates and added sugars, particularly fructose, which is metabolised primarily in the liver.

• Increase consumption of vegetables, wholegrains, legumes and oily fish, consistent with a Mediterranean-style dietary pattern. The EASL-EASD-EASO 2024 guidelines identify this pattern as having the strongest current evidence base for liver health in MASLD.^[13]

• Limit or eliminate alcohol. UK Chief Medical Officers advise that the low-risk drinking guideline is no more than 14 units per week spread over three or more days, but people with more advanced liver disease may be advised by their clinician to abstain completely.^[16] Follow the advice of your GP or specialist.

• Be cautious with very low-calorie diets. Rapid weight loss can carry risks including gallstone formation, and any very low-calorie approach should be undertaken only under medical supervision.

Regular physical activity, including both aerobic exercise and resistance training, has been shown to reduce liver fat independently of weight loss. The UK Chief Medical Officers' Physical Activity Guidelines recommend at least 150 minutes of moderate-intensity activity per week for adults, and NHS guidance reflects this. Managing associated conditions such as type 2 diabetes, high blood pressure and raised cholesterol is also essential, as these contribute to disease progression.

A registered dietitian can provide personalised dietary advice tailored to your health status and preferences. Your GP can refer you to relevant NHS services, including structured weight management programmes, if appropriate.

Scientific References

1. Non-alcoholic fatty liver disease (NAFLD): assessment and management (NG49).
2. Non-alcoholic fatty liver disease (NAFLD): assessment and management (NG49) – recommendations for research.
3. GID-TA11477 draft scope (post-referral) – MASLD/MASH: no medicines currently approved in the UK.
4. Resmetirom (Rezdiffra) authorised to treat metabolic dysfunction-associated steatohepatitis (MASH) in adults.
5. Non-alcoholic fatty liver disease (NAFLD).
6. Iodine deficiency in the UK – dietetic implications.
7. Iodine.
8. The essential role of iodine in the diet.
9. Statement on the potential effects that excess iodine intake may have during preconception, pregnancy and lactation.
10. Foods to avoid in pregnancy.
11. Borderline products: how to tell if your product is a medicine.
12. Borderlines with medical devices and other products in Great Britain.
13. EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD).
14. UK Chief Medical Officers' physical activity guidelines.
15. Physical activity guidelines for adults aged 19 to 64.
16. Alcohol consumption: advice on low risk drinking – UK Chief Medical Officers' guidelines.
17. Structured Exercise Interventions and Hepatic-Metabolic Outcomes in Adults with MASLD: A Narrative Review of Randomized Controlled Trials.
18. The effect of body mass index change on cholelithiasis after laparoscopic sleeve gastrectomy: a single centre experience.
19. Dietary fiber's benefit for gallstone disease prevention during rapid weight loss in obese patients.

Frequently Asked Questions